Maria Baccoro
Psychosomatic Medicine · Fresno, CANPI 1295984607
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 205 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 24.8% of the total. Reporting peaked in 2019 at $2,912 and has fallen 92.6% since, to $215 in 2023. Among psychosomatic medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 205 payments — averaging $31.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$1K
- Alkermes, Inc.$856
- Neurocrine Biosciences, Inc.$765
- Johnson & Johnson$595
- Teva Pharmaceuticals USA, Inc.$420
- plus $1K from 8 others
What the payments were for
- Food & beverage$6,46499%
- Education$881%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 25 | $1,628 |
| AbbVie(2 entities) | 65 | $1,125 |
| Alkermes, Inc. | 12 | $856 |
| Neurocrine Biosciences, Inc. | 9 | $765 |
| Johnson & Johnson | 10 | $595 |
| Teva Pharmaceuticals USA, Inc. | 16 | $420 |
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $399 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $309 |
| Sunovion Pharmaceuticals Inc. | 3 | $133 |
| Lundbeck LLC | 7 | $127 |
| Avanir Pharmaceuticals, Inc. | 1 | $125 |
| Shire North American Group Inc | 3 | $35 |
| Alfasigma USA, Inc. | 2 | $24 |
| Adlon Therapeutics L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$2,000
- INGREZZA$748
- ABILIFY MAINTENA$721
- REXULTI$699
- ARISTADA INITIO$500
- LYBALVI$500
- INVEGA SUSTENNA$231
- INVEGA TRINZA$231
- VRAYLAR$125
- AUSTEDO$125
- NUEDEXTA$125
- CAPLYTA$114
- LATUDA$109
- SPRAVATO$104
How this compares
$6,553 in reported general payments places this provider in the 95th percentile of 22 psychosomatic medicine providers in California.
Other psychosomatic medicine in Fresno
- Carol BanyasDanville$2K
- Oana GalickiBeverly Hills$1K
- Kerry MitchellSan Francisco$1K
- Daniel FishmanPalo Alto$1K
- Karen KleemanSanta Monica$799
- Renee GarciaPalo Alto$735
- Jose MaldonadoStanford$679
- Shanthi GowrinathanSanta Monica$661
- Julie PanLos Angeles$289
- Sheila LahijaniStanford$274
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.